Value of 123I-MIBG scintigraphy in paraganglioma

Neuroendocrinology

Volumn 91, Issue 1, 2010, Pages 94-100

  Milardovic, Renata ^a,b   Corssmit, Eleonora P M ^b   Stokkel, Marcel ^b  

^a UNIVERSITY OF SARAJEVO   (Bosnia and Herzegovina)

^b LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

123I MIBG scintigraphy; Detection; Paragangliomas

Indexed keywords

(3 IODOBENZYL)GUANIDINE I 123; CATECHOLAMINE; PENTETREOTIDE IN 111; (3 IODOBENZYL)GUANIDINE; DIAGNOSTIC AGENT; INDIUM; OCTREOTIDE; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CATECHOLAMINE BLOOD LEVEL; CATECHOLAMINE URINE LEVEL; COMPUTER ASSISTED TOMOGRAPHY; DIAGNOSTIC IMAGING; FEMALE; FOLLOW UP; HUMAN; IMAGE ANALYSIS; MAJOR CLINICAL STUDY; MALE; NUCLEAR MAGNETIC RESONANCE IMAGING; PARAGANGLIOMA; PHEOCHROMOCYTOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR LOCALIZATION; TUMOR SCINTISCANNING; ABDOMINAL TUMOR; EVALUATION; HEAD AND NECK TUMOR; METASTASIS; METHODOLOGY; MIDDLE AGED; MULTIPLE CANCER; PATHOLOGY; SCINTISCANNING; THORAX TUMOR;

3-IODOBENZYLGUANIDINE; ABDOMINAL NEOPLASMS; ADULT; AGED; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; INDIUM RADIOISOTOPES; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; NEOPLASM METASTASIS; NEOPLASMS, MULTIPLE PRIMARY; OCTREOTIDE; PARAGANGLIOMA; PHEOCHROMOCYTOMA; RADIONUCLIDE IMAGING; RADIOPHARMACEUTICALS; THORACIC NEOPLASMS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 76749121803     PISSN: 00283835     EISSN: None     Source Type: Journal    
DOI: 10.1159/000242499     Document Type: Article

References (16)

1. Hanson MW: Scintigraphic evaluation of neuroendocrine tumors. Appl Radiol 2001; 30: 11-17.
2. Koopmans KP: Metabolic PET Tracers for Neuroendocrine Tumors; thesis University of Groningen, 2008.
3. Ilias I, Pacak K: A clinical overview of pheochromocytomas/ paragangliomas and carcinoid tumors. Nucl Med Biol 2008; 35(suppl 1):27-34.
4. Shapiro B, Fig LM, Gross MD, Shulkin BL, Sisson JC: Neuroendocrine tumors; in Aktolun C, Tauxe WN (eds): Nuclear Oncology. Berlin, Springer, 1999, pp 3-32.
5. Gross MD, Shapiro B, Bui C, Shulkin BL, Sisson JC: Adrenal scintigraphy and metaiodobenzylguanidine therapy of neuroendocrine tumors; in Sandler MP, Coleman RE, Patton JA, Wackers FJT, Gottschalk A (eds): Diagnostic Nuclear Medicine, ed 4. Philadelphia, Lippincott Williams & Wilkins, 2003, pp 715-734.
6. James O, Coleman RE: Radioiodinated MIBG in paraganglioma and pheochromocytoma: previous results and early experiences using no-carrier-added MIBG. Nucl Med Biol 2008; 35(suppl 1):63-76.
7. Koopmans KP, Jager PL, Kema IP, Kerstens MN, Albers F, Dullaart RPF: In-111-octreotide is superior to I-123-metaiodobenzylguanidine for scintigraphic detection of head and neck paragangliomas. J Nucl Med 2008; 49: 1232-1237.
8. Ruffini V, Calcagni ML, Baum R: Imaging of neuroendocrine tumors. Semin Nucl Med 2006; 36: 228-247.
9. Troncone L, Rufini V: MIBG in diagnosis of neuroendocrine tumors; in Ell PJ, Gambhir SS (eds): Nuclear Medicine in Clinical Diagnosis and Treatment. Edinburgh, Churchill Livingstone, 2004, vol 1, pp 83-95.
10. Pryma D, Divgi C: Meta-iodobenzyl guanidine for detection and staging of neuroendocrine tumors. Nucl Med Biol 2008; 35(suppl 1):3-8.
11. Elgazzar AH, Gelfand MJ, Washburn LC, Clark J, Nagaraj N, Cummings D, Hughes J, Maxxon HR 3rd: I-123 MIBG scintigraphy in adults, a report of clinical experience. Clin Nucl Med 1995; 20: 147-152.
12. Chrisoulidou A, Kaltsas G, Ilias I, Grossman AB: The diagnosis and management of malignant pheochromocytoma and paraganglioma. Endocr Relat Cancer 2007; 14: 569-585.
13. Kwekkeboom DJ, van Urk H, Pauw BKH, Lamberts SWJ, Kooij PPM, Hoogma R, Krenning EP: Octreotide scintigraphy for the detection of paragangliomas. J Nucl Med 1993; 34: 873-878.
14. de Herder WW, Kwekkeboom DJ, Valkema R, Feelders RA, van Aken MO, Lamberts SW, van der Lely AJ, Krenning EP: Neuroendocrine tumors and somatostatin: imaging techniques. J Endocrinol Invest 2005; 28(11 Suppl International):132-136.
15. Kwekkeboom DJ, Krenning EP: Somatostatin receptor imaging. Semin Nucl Med 2002; 32: 84-91.
16. van der Harst E, de Herder WW, Bruining HA, Bonjer HJ, de Krijger RR, Lamberts SWJ, van den Meiracker AH, Boomsma F, Stijnen T, Krenning EP, Bosman FT, Kwekkeboom DJ: I-123-metaiodobenzylguanidine and In-111-octreotide uptake in benign and malignant pheochromocytomas. J Clin Endocrinol Metab 2001; 86: 685-693.